SuperworthTScan Therapeutics market cap TCRX
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $13.8M
- Highest close in our data
- $474.7M
- May 2024
TScan Therapeutics is worth $13.8M at the close on Oct 23, 2026, at $0.20 a share.
That is down 89% over the last year and down 93% over five years.
Its highest close in our data was $474.7M in May 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $13.8M | $13.8M | $82.3M | −77% |
| 2025 | $60.2M | $50.8M | $163.8M | −63% |
| 2024 | $163.3M | $152.1M | $474.7M | −41% |
| 2023 | $278.8M | $43.1M | $313.7M | +647% |
| 2022 | $37.3M | $12.8M | $96.1M | −55% |
| 2021 | $83.8M | $83.8M | $264.3M | n/a |
Against its peers
Companies in Healthcare nearest TScan Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| TCRXTScan Therapeutics | $13.8M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on TScan Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.